Stock listing
MOOD Stock Price, News, Filings & Events — Doseology Sciences, Inc.
Selected listing: MOOD · NEO · CAD · CA
This page tracks Doseology Sciences, Inc.'s MOOD:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MOOD:NEO. MOOD:NEO is the stock-level entry point for investors researching Doseology Sciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Doseology Sciences, Inc. is a public company trading under the ticker MOOD on the Canadian market. The company has a market capitalization of approximately $1.22 million. Doseology focuses on developing innovative solutions in the field of psychedelics and mental health.
- Ticker
- MOOD:NEO
- Asset type
- Stock
- Market cap
- $1.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- NEO
- Currency
- CAD
Doseology Sciences, Inc. MOOD:NEO stock context
This page tracks Doseology Sciences, Inc.'s MOOD:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MOOD:NEO. MOOD:NEO is the stock-level entry point for investors researching Doseology Sciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Doseology Sciences, Inc. is a public company trading under the ticker MOOD on the Canadian market. The company has a market capitalization of approximately $1.22 million. Doseology focuses on developing innovative solutions in the field of psychedelics and mental health.
Latest news from Doseology Sciences, Inc.
Doseology Announces Extension to Closing of Private Placement
June 29, 2026
Doseology Announces Extension to Closing of Private Placement and Resignation of Officer
May 15, 2026
Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform
March 30, 2026
Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category
March 11, 2026
Doseology Launches Feed That Brain® Oral Stimulant Pouches in the U.S. Through Direct-to-Consumer Pilot
March 4, 2026
Research Doseology Sciences, Inc.
Doseology Sciences, Inc. investor report
Review AI stock analysis and investor report context for MOOD:NEO.
Doseology Sciences, Inc. company profile
View the public company page for Doseology Sciences, Inc. on 6ix.
Doseology Sciences, Inc. news
Read company news and market updates connected to Doseology Sciences, Inc..
Doseology Sciences, Inc. investor events
Find investor webinars, events, and replay context for Doseology Sciences, Inc..
Alternate listings
MOOD:CSE
CA · CAD
Alternate listing for Doseology Sciences, Inc.; the primary context on this page is MOOD:NEO.
DOSEF:OTC
US · USD
Alternate listing for Doseology Sciences, Inc.; the primary context on this page is MOOD:NEO.
VU70:FWB
DE · EUR
Alternate listing for Doseology Sciences, Inc.; the primary context on this page is MOOD:NEO.